Timmerman Pharmacy is categorized under Commercial Art Galleries in New York City, NY and active since 1956.
Timmerman Pharmacy was established in 1956, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Art Galleries business, which does work in the B2B market, and is classified as a Commercial Art Galleries, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Martin Keen, Owner at the company’s single location by writing to 799 Lexington Avenue, New York City, New York NY 10065 or by phoning (212) 838-6450. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Timmerman Pharmacy |
| Contact Person: | Martin Keen, Owner |
| Address: | 799 Lexington Avenue, New York City, New York 10065 |
| Phone Number: | (212) 838-6450 |
| Website Address: | newtimrx.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1956 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Art Galleries |
| SIC Code: | 7999 |
| NAICS Code: | 4461100 |
| Share This Business: |
Timmerman Pharmacy was started in 1956 to provide professional Commercial Art Galleries under the SIC code 7999 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Martin Keen, Owner for inquiries that concern Timmerman Pharmacy by calling the company number (212) 838-6450, as your correspondence is most welcome. Additionally, the physical location of the single location of Timmerman Pharmacy can be found at the coordinates 40.764098,-73.966735 as well as the street address 799 Lexington Avenue in New York City, New York 10065.
For its online presence, you may visit Timmerman Pharmacy’s website at newtimrx.com and engage with its social media outlets through on Twitter and on Facebook.